Member Voice

Have Something to Share?

CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website.

Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.

Search

Search
Contributors
  • ACROBiosystems (1)
  • Algen Biotechnologies (1)
  • Argenx (1)
  • Avance Clinical (5)
  • Biointron (3)
  • Brainstorm Therapeutics (1)
  • Centogene (4)
  • CleanSpace (8)
  • Digital Science (3)
  • Encellin (1)
  • Fauna Bio (1)
  • Fenix Group (1)
  • Flannery Sales Systems (5)
  • GeneFab (1)
  • GO-Biz (2)
  • Halloran (1)
  • Hogan Lovells Cadwalader (1)
  • HOPO Therapeutics (1)
  • iNFixion Biosciences (1)
  • Inflammatix (1)
  • MabPlex (5)
  • MBC BioLabs (5)
  • Medscape (6)
  • Nucleus Biologics (2)
  • Nutromics (2)
  • o2h Discovery (2)
  • Oncotelic (1)
  • OPM Biosciences (1)
  • Otsuka (1)
  • ProBio (1)
  • Raydient Oximetry (1)
  • Royale International (8)
  • Sift Biosciences (1)
  • Siolta Therapeutics (1)
  • Slingshot Biosciences (1)
  • SU Group (1)
  • TippingPoint Biosciences (1)
  • Unnatural Products (1)
  • Voro Therapeutics (1)
  • WACKER (2)
  • X-Therma (1)
Member Voice

Accelerating the Path to IND: Integrated ADC and Bispecific Workflows

MabPlex

The transition from lead candidate to Investigational New Drug (IND) filing is often delayed by the logistical complexity of managing...

Member Voice

Five Key Areas of a Buyer’s Decision Qualification

There are five key areas that sellers must understand from prospective customers that will be used to make a purchasing...

Member Voice

Enhance Your Recruitment & Retention Strategy For Rare Kidney Disease Trials

Breakthroughs in genetic understanding alongside the growing shift toward accommodating orphan drugs have led to an upswing in clinical trials...

Member Voice

September Update: Antibody Industry Trends (Q3 2026 Insights, Trends & Analysis)

Biointron’s Q3 2026 Antibody Industry Trends report aims to explore the events and trends of the biopharmaceutical industry in July,...

Member Voice

How Australia’s Leading CRO Is Driving Biotech’s Acceleration From First-In-Human To Global Markets

Avance Clinical

CEO of Avance Clinical, Mark Harvill found his way into the clinical research space by chance, or perhaps more accurately,...

Member Voice

Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead Slingshot Bio into Its Next Chapter

Slingshot Biosciences

Slingshot Biosciences, a leader in precision-engineered cell mimics for flow cytometry, announced that Dr. Nimisha Srivastava has been appointed Chief...

Industry

iNFixion seeks NF1 treatment by enhancing what the body is doing right

iNFixion Biosciences

Since discovering his daughter’sNF1, a rare disease impacting 1 in 3000 people, nearly 25 years ago, Sarnoff has slowly transformed...

Industry

BrainStorm Therapeutics combines brain organoids and AI for CNS drug discovery

Brainstorm Therapeutics

Artificial intelligence is opening new possibilities for drug discovery. But in neuroscience, AI is only as powerful as the biological...

Member Voice

Otsuka Announces Transformative Phase 3 FUSION Results for Ulefnersen, Bringing the FUS-ALS Community Closer to a Potential Targeted Treatment

Otsuka

Otsuka Pharmaceutical Development & Commercialization, Inc. and Ionis Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 FUSION...

Have Something to Share?

CLS members can submit articles, press releases, whitepapers, and/or blogs to be featured on the ‘Member Voice’ section of our website.

Not yet a member? Join CLS today to start taking advantage of this exclusive member benefit.

Content Archive